| Literature DB >> 25873746 |
Robert A Jenny1, Claire Hirst1, Sue Mei Lim1, Adam L Goulburn1, Suzanne J Micallef1, Tanya Labonne1, Anthony Kicic1, Kak-Ming Ling1, Stephen M Stick1, Elizabeth S Ng1, Alan Trounson1, Antonietta Giudice1, Andrew G Elefanty1, Edouard G Stanley2.
Abstract
UNLABELLED: Airway epithelial cells generated from pluripotent stem cells (PSCs) represent a resource for research into a variety of human respiratory conditions, including those resulting from infection with common human pathogens. Using an NKX2.1-GFP reporter human embryonic stem cell line, we developed a serum-free protocol for the generation of NKX2.1(+) endoderm that, when transplanted into immunodeficient mice, matured into respiratory cell types identified by expression of CC10, MUC5AC, and surfactant proteins. Gene profiling experiments indicated that day 10 NKX2.1(+) endoderm expressed markers indicative of early foregut but lacked genes associated with later stages of respiratory epithelial cell differentiation. Nevertheless, NKX2.1(+) endoderm supported the infection and replication of the common respiratory pathogen human rhinovirus HRV1b. Moreover, NKX2.1(+) endoderm upregulated expression of IL-6, IL-8, and IL-1B in response to infection, a characteristic of human airway epithelial cells. Our experiments provide proof of principle for the use of PSC-derived respiratory epithelial cells in the study of cell-virus interactions. SIGNIFICANCE: This report provides proof-of-principle experiments demonstrating, for the first time, that human respiratory progenitor cells derived from stem cells in the laboratory can be productively infected with human rhinovirus, the predominant cause of the common cold. ©AlphaMed Press.Entities:
Keywords: Differentiation; GFP; HRV; Human embryonic stem cells; Lung; NKX2.1; Respiratory endoderm; Rhinovirus
Mesh:
Substances:
Year: 2015 PMID: 25873746 PMCID: PMC4449101 DOI: 10.5966/sctm.2014-0274
Source DB: PubMed Journal: Stem Cells Transl Med ISSN: 2157-6564 Impact factor: 6.940